Takabayashi K,, L, L., Chisholm D,, Zubeldia Ortuño, J. M., & AA, H. (2019). Intranasal Immunotherapy Is More Effective Than Intradermal Immunotherapy for the Induction of Airway Allergen Tolerance in Th2-Sensitized Mice.
Citación estilo ChicagoTakabayashi K,, Libet L, Chisholm D, José Manuel Zubeldia Ortuño, y Horner AA. Intranasal Immunotherapy Is More Effective Than Intradermal Immunotherapy for the Induction of Airway Allergen Tolerance in Th2-Sensitized Mice. 2019.
Cita MLATakabayashi K,, et al. Intranasal Immunotherapy Is More Effective Than Intradermal Immunotherapy for the Induction of Airway Allergen Tolerance in Th2-Sensitized Mice. 2019.
Precaución: Estas citas no son 100% exactas.